These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 12847692

  • 1. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse.
    Ong VH, Evans LA, Shiwen X, Fisher IB, Rajkumar V, Abraham DJ, Black CM, Denton CP.
    Arthritis Rheum; 2003 Jul; 48(7):1979-91. PubMed ID: 12847692
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [Abstract] [Full Text] [Related]

  • 3. Transgenic analysis of scleroderma: understanding key pathogenic events in vivo.
    Denton CP, Abraham DJ.
    Autoimmun Rev; 2004 Jun; 3(4):285-93. PubMed ID: 15246024
    [Abstract] [Full Text] [Related]

  • 4. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.
    Galindo M, Santiago B, Rivero M, Rullas J, Alcami J, Pablos JL.
    Arthritis Rheum; 2001 Jun; 44(6):1382-6. PubMed ID: 11407698
    [Abstract] [Full Text] [Related]

  • 5. Activation of a fibroblast-specific enhancer of the proalpha2(I) collagen gene in tight-skin mice.
    Denton CP, Zheng B, Shiwen X, Zhang Z, Bou-Gharios G, Eberspaecher H, Black CM, de Crombrugghe B.
    Arthritis Rheum; 2001 Mar; 44(3):712-22. PubMed ID: 11263787
    [Abstract] [Full Text] [Related]

  • 6. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S, Ghosh AK, Pannu J, Mori Y, Takagawa S, Chen G, Trojanowska M, Gilliam AC, Varga J.
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Yanaba K, Komura K, Kodera M, Matsushita T, Hasegawa M, Takehara K, Sato S.
    Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
    [Abstract] [Full Text] [Related]

  • 8. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N, Maurer B, Akhmetshina A, Venalis P, Dees C, Zerr P, Palumbo K, Zwerina J, Nevskaya T, Gay S, Distler O, Schett G, Distler JH.
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [Abstract] [Full Text] [Related]

  • 9. A CD40-CD154 interaction in tissue fibrosis.
    Kawai M, Masuda A, Kuwana M.
    Arthritis Rheum; 2008 Nov; 58(11):3562-73. PubMed ID: 18975310
    [Abstract] [Full Text] [Related]

  • 10. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells.
    Distler JH, Jüngel A, Caretto D, Schulze-Horsel U, Kowal-Bielecka O, Gay RE, Michel BA, Müller-Ladner U, Kalden JR, Gay S, Distler O.
    Arthritis Rheum; 2006 Jan; 54(1):214-25. PubMed ID: 16385517
    [Abstract] [Full Text] [Related]

  • 11. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
    Distler JH, Jüngel A, Kowal-Bielecka O, Michel BA, Gay RE, Sprott H, Matucci-Cerinic M, Chilla M, Reich K, Kalden JR, Müller-Ladner U, Lorenz HM, Gay S, Distler O.
    Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
    [Abstract] [Full Text] [Related]

  • 12. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK, Bhattacharyya S, Lakos G, Chen SJ, Mori Y, Varga J.
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [Abstract] [Full Text] [Related]

  • 13. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH, Jüngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, Gay S, Distler O.
    Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
    Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O.
    Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
    [Abstract] [Full Text] [Related]

  • 16. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J, Gardner H, Shearstone JR, Smith E, Trojanowska M.
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [Abstract] [Full Text] [Related]

  • 17. Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis.
    Distler JH, Akhmetshina A, Schett G, Distler O.
    Rheumatology (Oxford); 2009 Feb; 48(2):98-103. PubMed ID: 18984611
    [Abstract] [Full Text] [Related]

  • 18. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C, Parel Y, De Luca C, Tyndall A, Akesson A, Scheja A, Dayer JM.
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
    Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S.
    J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
    [Abstract] [Full Text] [Related]

  • 20. Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis.
    Reich N, Tomcik M, Zerr P, Lang V, Dees C, Avouac J, Palumbo K, Horn A, Akhmetshina A, Beyer C, Xie W, Bennett BL, Distler O, Schett G, Distler JH.
    Ann Rheum Dis; 2012 May; 71(5):737-45. PubMed ID: 22258492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.